PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics
PhaseBio Pharmaceuticals, Inc. (PHAS)
Today's Latest Price: $3.91 USD
0.26 (7.12%)
Updated Nov 13 8:00pm
Add PHAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PHAS Daily Price Range
PHAS 52-Week Price Range
PHAS Stock Price Chart More Charts
PHAS Price/Volume Stats
| Current price | $3.91 |
| Prev. close | $3.65 |
| Day low | $3.61 |
| Day high | $3.91 |
| 50-day MA | $4.37 |
| 200-day MA | $7.91 |
| 52-week high | $16.65 |
| 52-week low | $2.55 |
| Volume | 179,000 |
| Avg. volume | 292,535 |
| Dividend yield | N/A |
| Market Cap | 112.21M |
PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio
PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.
Top Stories View All
Shares of Apple (AAPL) Hit All-Time Highs: Buy, Sell, or Hold?
Best & Worst Performing Stock Industries for November 13, 2019
Best & Worst Performing Small Cap Stocks for November 13, 2019
Best & Worst Performing Mid Cap Stocks for November 13, 2019
Best & Worst Performing Large Cap Stocks for November 13, 2019
View All Top Stories
Loading social stream, please wait...